Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 19/20 | 0.74 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1448562 | 0.93 | GPR119 (0.74) | GPR119KCNH2 | |
| SCHEMBL1449135 | 0.86 | GPR119 (0.73) | GPR119KCNH2 | |
| SCHEMBL1448634 | 0.85 | GPR119 (1.00) | GPR119 | |
| SCHEMBL1448631 | 0.85 | GPR119 (1.00) | GPR119 | |
| SCHEMBL1449271 | 0.80 | GPR119 (0.72) | GPR119KCNH2 | |
| SCHEMBL1448485 | 0.78 | GPR119 (1.00) | GPR119 | |
| SCHEMBL1448487 | 0.78 | GPR119 (1.00) | GPR119 | |
| SCHEMBL1365825 | 0.75 | HDAC1 (0.42) | GPR119 | |
| SCHEMBL1367540 | 0.72 | HDAC1 (0.41) | GPR119 | |
| SCHEMBL1448916 | 0.71 | GPR119 (0.43) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065706-A1 | Therapeutic Agents 812 | ASTRAZENECA AB (SE) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065706-A1 | Therapeutic Agents 812 | GPR119, GPR84, GPR132 | GPR119 1/4885KCNH2 1798/4885CYP4F2 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.